Home health remedies Sorry, Shkreli: Supreme Court rebuffs ex-pharma CEO’s final appeal

Sorry, Shkreli: Supreme Court rebuffs ex-pharma CEO’s final appeal

13
0
SHARE

Martin Shkrelli, the disgraced former CEO of Retrophin currently serving a seven-year sentence for securities fraud and conspiracy, was hoping for a SCOTUS hail mary after multiple appeals fell flat. Turns out the court wasn’t interested in hearing Shkreli’s pleas at all. 

The U.S. Supreme Court on Monday denied hearing Shkreli’s appeal to overturn his 2017 fraud conviction after his disastrous run as head of biotech Retrophin. Shkreli was also forced to forfeit $7.36 million in his conviction.

With that final rebuff, Shkreli will likely see the inside of a jail cell for the next five years––a sentence that could grow longer after he was accused of running his business from behind bars. 

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

RELATED: Shkreli’s jail-cell business dealings draw scrutiny from the feds: WSJ

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

11 − 9 =